Your philanthropic support to the COVID-19 Impact Fund has enhanced and accelerated the broad work to conquer the new coronavirus, including advancing lifesaving research in new treatments, preventions, and cures. On October 1, Merck and Ridgeback announced their plan to seek Emergency Use Authorization (EUA) for Molnupiravir, an investigational oral antiviral therapeautic for COVID-19 that was discovered by researchers at Emory University.

Dr. Jonathan S. Lewin, Executive Vice President for Health Affairs at Emory University and CEO and Chair of the Board of Emory Healthcare shared, “this is a true breakthrough in the international fight against COVID-19, and our team at DRIVE deserves great credit for their work in bringing this drug to fruition. Congratulations to the DRIVE team and to all the Emory researchers whose work has contributed and led up to this important discovery. It is a wonderful example of the importance of academic research that improves lives and brings hope to millions.” 

Join us today, Wednesday, Oct. 6th at 11 am EDT, for a Facebook LIVE event with Emory University President Gregory L. Fenves and Emory's Dr. Jodie Guest to discuss Molnupiravir within the larger context of Emory's research eminence. Emory has in the past advanced the development of some of the world’s most important and valuable antiviral drugs, successfully taking treatments from bench to bedside. https://www.facebook.com/events/283208183445876?ref=newsfeed

Again thank you for your support in the fight against COVID-19. You can find more information on Molnupiravir at these sites.

https://news.emory.edu/stories/2021/10/eua_application_expected_for_molnupiravir_covid_19/index.html

https://news.emory.edu/tags/topic/molnupiravir/index.html

As a supporter of the COVID-19 Impact fund, you care about making a difference in health care and research. You can continue to support and uplift others by joining us virtually April 15-25 in celebration of National Volunteer Week. Here are two ways to spread encouragement and take action this month:

• Encourage: Public health practitioners have worked tirelessly in labs, hospitals, health departments, academic research centers, nonprofits, and more to combat the spread of COVID-19, both in the U.S. and around the globe.  \We would like to take this moment to recognize these people for who they are: unsung heroes. Please join us in extending gratitude by submitting a thank you message to an Emory public health hero who has impacted your life by using this form. Your message will be shared on our Emory social media channels throughout April and May.
• Act: Support Emory’s vaccination efforts through non-clinical volunteering at the Atlanta Northlake Vaccine Clinic. Volunteers** will assist with wayfinding, registration, waiting station after vaccination, restocking supplies, etc. Vaccination will be offered at the end of the shift! Register through the Emory Cares portal. **Must be directly Emory affiliated (alumni, faculty, staff, student, healthcare) to volunteer.

Thank you for your continued support of Emory’s health care response during the COVID-19 pandemic.

Your generosity through the Emory COVID-19 Impact Fund has allowed Emory to keep our community safe and deepen our understanding of this infectious disease. Our researchers have advanced antiviral medicine like remdesivir, developed fast and accurate virus tests, expanded antibody testing, furthered our understanding of immunity, and have created national guidelines on response protocols.

The COVID-19 Impact Fund has helped keep our health care workers safe with new PPE and equipment, as well as a program to sterilize PPE with vaporized hydrogen peroxide.

Even as the number of cases rise, we enter the new year with hope. Highly effective vaccines are being distributed around the world. Emory played a major role as the nation’s largest trial site for the Moderna mRNA vaccine. Now, that vaccine is being administered to health care workers and essential workers across the country.

“I’ve watched patients, families, friends, and my peers suffer the ravages of COVID-19,” says Kim Bently, Vice President of Operations for Emory Hillandale Hospital. “Getting the vaccine, for me, is the first step in the alleviation of that widespread suffering.”

Thanks to your support, Emory has also helped expand accessibility to testing and care across Georgia, including reopening school-based health centers in underserved communities.

Your ongoing support has carried these efforts through many challenging months. We are now fighting through a massive surge to keep Atlanta and Georgia safe until enough people are vaccinated. We encourage you to hare this message with your network and we hope that you will continue to support Emory’s COVID-19 research and response.

Your gift to the Emory COVID-19 Impact Fund advanced and accelerated Emory’s response to this pandemic.

Over the last five months, Emory has worked tirelessly to research and understand the novel coronavirus. We have learned how to care for patients more effectively with new treatments and protocols. We have discovered ways to protect ourselves and worked to educate our community on the measures of masking, social distancing, washing hands routinely, and monitoring our wellness to help stop the spread of this disease.

Thanks to in-kind gifts, we received more than 150,000 masks, 400,000 pairs of gloves, and 450 containers of wipes to protect our patients and caregivers.

Thanks to your support of the Emory COVID-19 Impact Fund, Emory has been able to care for patients—and their families—by furnishing more than 300 baby monitors, purchased to allow immobile ICU patients to communicate with family. This fund also allowed Emory Healthcare to purchase 50 critical care ventilators, as well as cutting-edge technology like eICU carts and telemedicine tablets to provide additional layers of critical care service.

Emory researchers are at the forefront of COVID-19 discovery, and this fund has supported critical success stories like these:

• COVID-19 vaccine tested at Emory is safe, generates immune response, early results show 
• Lung radiation helps coronavirus pneumonia patients recover faster, study says 
• Repurposing a cancer drug to reduce COVID-19 lung inflammation
• Phase 3 COVID-19 vaccine trials will begin soon, and volunteers are needed

Thank you for your gift to the COVID-19 Impact Fund. Your generosity helps make this progress possible.

No one can put it more succinctly than one of our patients who recently shared, “When the world shut down, Emory was still there. I feel honored to be a part of Emory’s community."

With the resurgence of infection rates in Georgia, the need for the fund has been elevated. To amplify this message and your impact, we encourage you to share with your network why you are proud to support the Emory COVID-19 Impact Fund via Facebook, Twitter, and LinkedIn.

An invitation to learn more about Emory’s role in the remdesivir clinical trial

Thank you for making a gift to the Emory COVID-19 Impact Fund.

We thought you might be interested in attending A Glimmer of Hope for Coronavirus Patients, a webinar about Emory’s role in the breakthrough clinical trial of the antiviral drug, remdesivir.

Featuring Dr. Aneesh Mehta, with the Emory Vaccine Center and Emory University School of Medicine, Division of Infectious Disease, the webinar will take place Tuesday, May 12, 1–2 p.m. EDT.

Register now.

Thanks to you—Emory’s #GivingTuesdayNow campaign was a great success. The homepage will continue to tell the story! Check momentum.emory.edu to see the total number of donors, which shows the ever-increasing strength and generosity of our community.

Thanks to you—Emory will continue to help members of our community and advance life-saving research. By standing together with thousands of other donors, you are helping fight this pandemic.  

Thanks to you—Emory continues to deliver more than 9,000 meals a week to keep frontline health care heroes energized and fed. We’ve delivered more than 40,000 meals in Atlanta to date.

Thanks to you—Emory is making progress in the fight to end COVID-19. This recent news about Emory’s remdesivir trial—has been hailed by Anthony Fauci, MD, the director of the National Institute of Allergy and Infectious Diseases (NIAID) as a gamechanger in the quest for new treatment.

Your gift is helping fund the way forward.

Emory thanks you.

You are part of Emory’s efforts in leading the fight against COVID-19. #GivingTuesdayNow is a new global day of giving and unity that will take place on May 5 as an emergency response to the unprecedented need caused by the novel coronavirus.

You have already contributed to the Emory COVID-19 Impact Fund (THANK YOU!) so now we ask you to take the next step of amplifying your impact. Energize your family, friends, and colleagues via email, text, or social media—or give them a call—inviting them to join you in taking an active step to fight the pandemic.

Two ways you can help:

1. Use the GivingTuesdayNow social toolkit for messaging suggestions and images.

2. Sign up as a volunteer fundraising ambassador. You will have a personalized link to track who makes a gift as a result of your efforts. Your ambassador dashboard also gives you access to additional peer-to-peer messaging ideas and images.

Use the links below to sign up as a fundraising ambassador for the causes you care about:

Emory COVID-19 Impact Fund- supporting Emory’s health care research and patient needs

Feed the Frontline- providing meals to our frontline health care workers in Atlanta

DRIVE to end COVID-19- supporting Drug Innovation Ventures at Emory’s research for a coronavirus cure

Healthcare Employee Hardship Fund- providing financial assistance for Emory Healthcare employees

Public Health Preparedness and Research Fund-  supporting research for pandemic preparedness

Emory Together Fund- supporting emergency relief for Emory University students, faculty, and staff

By promoting #GivingTuesdayNow and #EmoryTogether, you are helping to fight the pandemic. Thank you!

Your gift to the COVID-19 Impact Fund is already making an impact. Did you read the news?

Emory develops diagnostic antibody blood test to determine antibody responses to COVID-19

Unlike many other crowdfunding sites, Emory’s Momentum platform does not take a cut of the proceeds.

This means 100% of your gift has gone directly to the COVID-19 Impact Fund.

We know there are still many steps to go before we conquer COVID-19, but Emory’s diagnostic antibody test is an exciting development.

“The results from these antibody tests will have important implications for determining our next steps in responding to this pandemic,” says John Roback, MD, PhD, executive vice chair for clinical operations in the Department of Pathology and Laboratory Medicine and medical director of Emory Medical Laboratories.

Thank you for helping Emory lead the way. You can help advance lifesaving research by encouraging your Facebook, Twitter, and LinkedIn networks to support Emory’s COVID-19 Impact Fund.

Thanks to your generosity, we have already raised more than $3,000 for the Emory COVID-19 Impact Fund. Your support allows Emory to make an immediate impact towards combating the COVID-19 pandemic.

Emory has provided a wide array of information and resources on COVID-19 to the community, including online risk assessments, clinical trials, FAQs, and expert input for both the media and community guidelines. Emory University and Emory Healthcare continue to be on the frontline of fighting this disease.

To amplify this message and your impact, we encourage you to share with your network why you donated to the Emory COVID-19 Impact Fund via Facebook, Twitter, and LinkedIn.

As members of the Emory community, we’re all in this together. Before we can even begin to measure the toll COVID-19 will take on our lives, you have already stepped in to help, and we are inspired by your kindness.

Your generosity and care are what truly define and unite the Emory community.

Thank you.